Evidence map›Paper›PMID 39861763›Full record

ArticlePharmaceutics2025

Amphotericin B Encapsulation in Polymeric Nanoparticles: Toxicity Insights via Cells and Zebrafish Embryo Testing.

Magno Maciel-Magalhães, Renata Jurema Medeiros, Nayara Cecília do Couto Guedes, Thais Morais de Brito, Gabriele Fátima de Souza, Beatriz Rodrigues Canabarro, Fausto Klabund Ferraris, Fábio Coelho Amendoeira, Helvécio Vinicius Antunes Rocha, Beatriz Ferreira de Carvalho Patricio and 1 more

Abstract read
In one paragraph

Article in Pharmaceutics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Article
  6. Innovative antifungal strategies to combat drug-resistantFrontiers in cellular and infection microbiology · 2025
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Magno Maciel-MagalhãesPrograma de Pós-Graduação em Pesquisa Translacional em Fármacos e Medicamentos (PPG-PTFM), Fundação Oswaldo Cruz (Fiocruz), Rio de Janeiro 21040-900, Brazil.ORCID 0000-0003-3438-1481
Renata Jurema MedeirosDepartamento de Farmacologia e Toxicologia, Instituto Nacional de Controle de Qualidade em Saúde (INCQS), Fundação Oswaldo Cruz (Fiocruz), Rio de Janeiro 21040-900, Brazil.ORCID 0000-0003-2991-1265
Nayara Cecília do Couto GuedesDepartamento de Farmacologia e Toxicologia, Instituto Nacional de Controle de Qualidade em Saúde (INCQS), Fundação Oswaldo Cruz (Fiocruz), Rio de Janeiro 21040-900, Brazil.
Thais Morais de BritoPrograma de Pós-Graduação em Vigilância Sanitária (PPG-VISA), Fundação Oswaldo Cruz (Fiocruz), Rio de Janeiro 21040-900, Brazil.
Gabriele Fátima de SouzaDepartamento de Farmacologia e Toxicologia, Instituto Nacional de Controle de Qualidade em Saúde (INCQS), Fundação Oswaldo Cruz (Fiocruz), Rio de Janeiro 21040-900, Brazil.
Beatriz Rodrigues CanabarroInstituto Alberto Luiz Coimbra de Pós-Graduação e Pesquisa em Engenharia (COPPE), Universidade Federal do Rio de Janeiro (UFRJ), Rio de Janeiro 21941-594, Brazil.
Fausto Klabund FerrarisPrograma de Pós-Graduação em Vigilância Sanitária (PPG-VISA), Fundação Oswaldo Cruz (Fiocruz), Rio de Janeiro 21040-900, Brazil.ORCID 0000-0001-9434-3503
Fábio Coelho AmendoeiraPrograma de Pós-Graduação em Vigilância Sanitária (PPG-VISA), Fundação Oswaldo Cruz (Fiocruz), Rio de Janeiro 21040-900, Brazil.ORCID 0000-0003-3573-5261
Helvécio Vinicius Antunes RochaPrograma de Pós-Graduação em Pesquisa Translacional em Fármacos e Medicamentos (PPG-PTFM), Fundação Oswaldo Cruz (Fiocruz), Rio de Janeiro 21040-900, Brazil.ORCID 0000-0002-7914-5039
Beatriz Ferreira de Carvalho PatricioPrograma de Pós-Graduação em Pesquisa Translacional em Fármacos e Medicamentos (PPG-PTFM), Fundação Oswaldo Cruz (Fiocruz), Rio de Janeiro 21040-900, Brazil.ORCID 0000-0002-2477-9798
Isabella Fernandes DelgadoPrograma de Pós-Graduação em Pesquisa Translacional em Fármacos e Medicamentos (PPG-PTFM), Fundação Oswaldo Cruz (Fiocruz), Rio de Janeiro 21040-900, Brazil.

Funding

Fundação Carlos Chagas Filho de Amparo à Pesquisa do Estado do Rio de Janeiro E-26/200.210/2023Fundação Carlos Chagas Filho de Amparo à Pesquisa do Estado do Rio de Janeiro E-26/211.757/2021Programa Inova Fiocruz - Ideias Inovadoras VPPIS-004-FIO-22-2-52Universidade Federal do Estado do Rio de Janeiro PPQ/UNIRIO Nº 03/2022
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

amphotericin Bpolycaprolactonepoly(lactic acid)polymeric nanoparticlestoxicityzebrafish

Identifiers

PMID39861763
PMCPMC11768399

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.